Mises Daily
Author:
Gennady Stolyarov II
Online Publish Date:
by the treaty. Under the current system, there at least exists the hope that other policy objectives pursued by the same governmental bodies — such as economic growth into the sphere of patents as well. ACTA would greatly restrict generic drug competition against expensive brand-name labels — creating still more pharmaceutical